Role of renal function and cardiac biomarkers (NT-proBNP and Troponin) in determining mortality and cardiac outcome in atheromatous renovascular disease

Kidney and Blood Pressure Research

Volumn 32, Issue 5, 2009, Pages 373-379

  Chrysochou, Constantina ^a   Manzoor, Sophie ^b   Wright, Julian ^b   Roberts, Stephen A ^c   Wood, Grahame ^a   McDowell, Garry ^b   Kalra, Philip A ^a  

^a HOPE HOSPITAL   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Atheromatous renovascular disease; Cardiac troponin; Cardiovascular events; N terminal pro brain natriuretic peptide; Renal artery stenosis; Renal function

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN;

ADULT; AGED; ARTICLE; ATHEROMA; CARDIOVASCULAR DISEASE; FEMALE; HIGH RISK PATIENT; HUMAN; KIDNEY ARTERY STENOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RENOVASCULAR DISEASE; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; RENAL ARTERY OBSTRUCTION; RISK FACTORS; SURVIVAL RATE; TROPONIN;

EID: 70350553970     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000254337     Document Type: Article

References (25)

1. Sarnak MJ, Levey AS, Schoolwerth AC, et al: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-2169.
2. Edwards MS, Craven TE, Burke GL, et al: Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study. Arch Intern Med 2005; 165: 207-213.
3. Wright JR, Shurrab AE, Cheung C, et al: A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. Am J Kidney Dis 2002; 39: 1153-1161.
4. Kalra PA, Guo H, Kausz AT, et al: Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int 2005; 68: 293-301.
5. Wood GN, Keevil B, Gupta J, et al: Serum troponin T measurement in patients with chronic renal impairment predicts survival and vascular disease: a 2 year prospective study. Nephrol Dial Transplant 2003; 18: 1610-1615.
6. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32(suppl 3):S112-S119.
7. Defilippi CR, Seliger SL, Maynard S, et al: Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality. Clin Chem 2007; 53: 1511-1519.
8. Wright JR, Shurrab AE, Cooper A, et al: Left ventricular morphology and function in patients with atherosclerotic renovascular disease. J Am Soc Nephrol 2005; 16: 2746-2753.
9. Christenson RH, Duh SH, Newby LK, et al: Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators. Clin Chem 1998; 44: 494-501.
10. Engel G, Rockson SG: Rapid diagnosis of myocardial injury with troponin T and CK-MB relative index. Mol Diagn Ther 2007; 11: 109-116.
11. Hobbs FD, Davis RC, Roalfe AK, et al: Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ 2002; 324: 1498.
12. Freda BJ, Tang WH, Van LF, et al: Cardiac troponins in renal insufficiency: review and clinical implications. J Am Coll Cardiol 2002; 40: 2065-2071.
13. Tagore R, Ling LH, Yang H, et al: Natriuretic peptides in chronic kidney disease. Clin J Am Soc Nephrol 2008; 3: 1644-1651.
14. Suresh M, Laboi P, Mamtora H, et al: Relationship of renal dysfunction to proximal arterial disease severity in atherosclerotic renovascular disease. Nephrol Dial Transplant 2000; 15: 631-636.
15. Wang TJ, Larson MG, Levy D, et al: Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350: 655-663.
16. Omland T, Sabatine MS, Jablonski KA, et al: Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. J Am Coll Cardiol 2007; 50: 205-214.
17. Austin WJ, Bhalla V, Hernandez-Arce I, et al: Correlation and prognostic utility of B-type natriuretic peptide and its amino-terminal fragment in patients with chronic kidney disease. Am J Clin Pathol 2006; 126: 506-512.
18. Manjunath G, Tighiouart H, Coresh J, et al: Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 2003; 63: 1121-1129. (Pubitemid 36315592)
19. Go AS, Chertow GM, Fan D, et al: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
20. Shurrab AE, MacDowall P, Wright J, et al: The importance of associated extra-renal vascular disease on the outcome of patients with atherosclerotic renovascular disease. Nephron Clin Pract 2003; 93:C51-C57.
21. Takami Y, Horio T, Iwashima Y, et al: Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. Am J Kidney Dis 2004; 44: 420-428.
22. Harnett JD, Foley RN, Kent GM, et al: Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 1995; 47: 884-890.
23. Guo H, Kalra PA, Gilbertson DT, et al: Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001. Circulation 2007; 115: 50-58.
24. Ito S, Murai S, Sugiura M, et al: Predictors of congestive heart failure in patients on maintenance hemodialysis. Circ J 2007; 71: 1424-1429.
25. Naganuma T, Sugimura K, Wada S, et al: The prognostic role of brain natriuretic peptides in hemodialysis patients. Am J Nephrol 2002; 22: 437-444.